Optimising the IgG-degrading enzyme treatment regimen for enhanced adeno-associated virus transduction in the presence of neutralising antibodies

  1. Ros-Gañán, I.
  2. Hommel, M.
  3. Trigueros-Motos, L.
  4. Tamarit, B.
  5. Rodríguez-García, E.
  6. Salas, D.
  7. Pérez, G.
  8. Douar, A.
  9. Combal, J.P.
  10. Benichou, B.
  11. Ferrer, V.
  12. González-Aseguinolaza, G.
Revista:
Clinical and Translational Immunology

ISSN: 2050-0068

Any de publicació: 2022

Volum: 11

Número: 2

Tipus: Article

DOI: 10.1002/CTI2.1375 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus